Skip to main content
4h ago

Science Corporation Secures $400 Million Funding, Valued at $3.5 Billion

Science Corporation, a medical technology startup founded by Max Hodak in 2021, has raised $400 million in a Series D funding round, as detailed in a

1 min read9 views5 tags
Originally reported bytechcrunch

Science Corporation, a medical technology startup founded by Max Hodak in 2021, has raised $400 million in a Series D funding round, as detailed in a company blog post.

Sources familiar with the deal indicate that investors have valued the startup at $3.5 billion for this financing. The round attracted participation from major backers including Khosla Ventures, the Ackman Oxman Institute, Tenet Healthcare, 885 Capital, Y Combinator, and PLC Neurotech.

Hodak, who began pursuing biotechnology after securing a spot in a graduate neuroscience lab, co-founded Science with the mission to leverage emerging technologies to interact with the brain. The company's debut product, PRIMA, is a wearable and implantable chip designed to aid individuals with age-related macular degeneration. Currently approved for use in Europe and available in Germany, the device is also undergoing trials for other potential applications.

With the newly secured funds, the company plans to introduce the device to the U.S. market via the FDA’s Humanitarian Device Exemption, which permits the use of experimental medical technology for rare conditions. Science has successfully convinced the FDA that advanced macular degeneration affecting both eyes is rare enough to qualify for this pathway.

While the company is currently pursuing this regulatory approval, its ultimate ambition is to connect directly to the human brain using a bio-hybrid sensor made from cultured neurons and silicon. Science is currently designing initial human trials for this technology in partnership with Yale neurosurgery professor Murat Günel. Günel told TechCrunch that this device holds promise for treating various brain injuries and illnesses, including Parkinson's disease.

#AI News#Brain Tech#Funding Round#Max Hodak#FDA Approval
ES
Editorial StaffEditor

The Editorial Staff at AIChief is a team of professional content writers with extensive experience in AI and marketing. Founded in 2025, AIChief has quickly grown into the largest free AI resource hub in the industry.

View all posts
Reader feedback

What did you think of this story?

User Comments

Filter:
No comments yet. Be the first to comment!
Continue reading
View all news